IMPACT OF GLP-1 RECEPTOR AGONIST ON CLINICAL OUTCOMES IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS: INSIGHTS FROM A LARGE-SCALE COHORT STUDY

被引：0
|
作者：
Niu, Chengu
Zhang, Jing
Arutla, Venkat
Zhu, Kaiwen
Malik, Sheza
Okolo, Patrick
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1826
引用
收藏
页码：S1424 / S1425
页数：2
相关论文
共 50 条
  • [1] Impact of GLP-1 Receptor Agonist Use in Patients With Steatotic Liver Disease and Type 2 Diabetes: A Retrospective Cohort Study
    Wood, Marci
    Kennedy, Amanda G.
    Khan, Sidra
    Hitt, Juvena R.
    Davis, Kayla
    Reddy, Sheela S.
    Gilbert, Matthew P.
    JOURNAL OF PHARMACY PRACTICE, 2024, 37 (06) : 1297 - 1302
  • [2] Outcomes of Percutaneous Coronary Intervention in Patients With Crohn's Disease and Ulcerative Colitis (from a Nationwide Cohort)
    Kobo, Ofer
    Mohamed, Mohamed O.
    Farmer, Adam D.
    Alraies, Chadi M.
    Patel, Tejas
    Sharma, Kamal
    Nolan, Jim
    Bagur, Rodrigo
    Roguin, Ariel
    Mamas, Mamas A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 130 : 30 - 36
  • [3] Association of Crohn's disease and ulcerative colitis with the risk of neurological diseases: a large-scale Mendelian randomization study
    Wang, Yinan
    Jia, Yiming
    Xu, Qingyun
    Yang, Pinni
    Sun, Lulu
    Liu, Yi
    Chang, Xinyue
    He, Yu
    Shi, Mengyao
    Guo, Daoxia
    Zhang, Yonghong
    Zhu, Zhengbao
    JOURNAL OF HUMAN GENETICS, 2024, 69 (11) : 565 - 571
  • [4] IMPACT OF GLP-1 AGONIST TREATMENT ON GERD OUTCOMES IN DIABETIC PATIENTS: INSIGHTS FROM A PROPENSITY-MATCHED STUDY IN THE UNITED STATES
    Hamid, Osama
    Qapaja, Thabet
    Trakroo, Sushrut
    Mohammed, Shaikhoon
    Awadalla, Mohanad
    Alsabbagh, Khaled
    Nanah, Alchirazi Rama
    Thota, Prashanthi N.
    GASTROENTEROLOGY, 2024, 166 (05) : S1003 - S1004
  • [5] Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative Disorders: A Large-Scale Propensity-Matched cohort study
    Siddeeque, Nabeela
    Hussein, Mohammad H.
    Abdelmaksoud, Ahmed
    Bishop, Julia
    Attia, Abdallah S.
    Elshazli, Rami M.
    Fawzy, Manal S.
    Toraih, Eman A.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [6] A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: Treatment outcomes of 847 patients in clinical practice
    Yokoyama, Yoko
    Matsuoka, Katsuyoshi
    Kobayashi, Taku
    Sawada, Koji
    Fujiyoshi, Tateshi
    Ando, Takafumi
    Ohnishi, Yoshifumi
    Ishida, Tetsuya
    Oka, Masashi
    Yamada, Masahiro
    Nakamura, Takashi
    Ino, Tomoko
    Numata, Toyoko
    Aoki, Hirofunni
    Sakou, Jun-ichi
    Kusada, Masahiro
    Maekawa, Tomoki
    Hibi, Toshifumi
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (09): : 981 - 991
  • [7] GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Physiology to Clinical Outcomes
    Rojano Toimil, Alba
    Ciudin, Andreea
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [8] GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
    Kawanami, Daiji
    Takashi, Yuichi
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [9] Vedolizumab Exposure in Pregnancy: Outcomes From Clinical Studies in Ulcerative Colitis and Crohn's Disease
    Mahadevan, Uma
    Dubinsky, Marla
    Vermeire, Severine
    Abhyankar, Brihad
    Lasch, Karen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S771 - S772
  • [10] Clinical Outcome Assessments in Pediatric Patients With Ulcerative Colitis and Crohn's Disease Receiving Biologics: A Retrospective Cohort Study
    Hunter, Theresa
    Komocsar, Wendy J.
    Liu, Chunyan
    Colletti, Richard B.
    Steiner, Steven J.
    Dotson, Jennifer L.
    Benkov, Keith
    Zhang, Nanhua
    Crandall, Wallace
    CROHNS & COLITIS 360, 2022, 4 (02)
12345